Welcome to our dedicated page for Curaleaf Hldgs news (Ticker: CURLF), a resource for investors and traders seeking the latest updates and insights on Curaleaf Hldgs stock.
Curaleaf Holdings, Inc. reports developments across its consumer cannabis business, including retail dispensary openings, medical and adult-use product brands, quarterly operating results, and international expansion. The company trades on the Toronto Stock Exchange as CURA and on OTCQX as CURLF.
Recurring updates cover brands such as Curaleaf, Select, Grassroots, Find, Dark Heart, Anthem, and Four 20 Pharma; U.S. dispensary activity; medical cannabis distribution in Germany and other international markets; share repurchase activity; board and shareholder matters; and regulatory topics affecting cannabis operations.
Curaleaf Holdings (OTCQX: CURLF) announced the opening of a new Curaleaf-branded dispensary near New Albany, Ohio, marking its 155th retail location nationwide. Located at 6500 N Hamilton Rd Westerville, the dispensary will serve both medical patients and adult-use customers with premium cannabis products including Select BRIQ vapes, Grassroots flower, JAMS edibles, and Find flower.
The dispensary, currently owned and operated by RC Retail 2 with support services from Curaleaf, represents potential future expansion for Curaleaf in Ohio, subject to regulatory approval. The location would become Curaleaf's fourth store in Ohio. The grand opening celebration is scheduled for September 12, 2025, featuring local vendors and special deals.
Curaleaf Holdings (OTCQX: CURLF) reported Q2 2025 financial results with total revenue of $315 million, up 1.5% quarter-over-quarter. The company achieved an adjusted gross margin of 49%, representing a 120 basis point increase year-over-year. International revenue showed strong growth of 62% year-over-year, reaching $41 million.
Key highlights include a $66 million adjusted EBITDA with a 21% margin, and quarter-end cash position of $102 million. The company secured a significant expansion opportunity with a new license to operate in Turkey's medical cannabis market. However, Curaleaf faced challenges with a net loss of $50.6 million from continuing operations and an 8% year-over-year revenue decline.
The company strengthened its leadership team with four senior executive appointments and expanded its retail presence to 154 locations nationwide. Curaleaf also completed the buyout of its international business minority partner, now owning 100% of Curaleaf International.
Curaleaf Holdings (OTCQX: CURLF) has announced the opening of a new medical cannabis dispensary in St. Augustine, Florida, marking its 68th location in Florida and 154th store nationwide. The new dispensary, located at 1280 Ponce De Leon Blvd., will begin serving medical patients on August 1, 2025.
The location will offer Curaleaf's complete portfolio of medical cannabis products, including the new Grassroots Dark Heart Collection, Select brand vapes and edibles, Florida-exclusive Reef flower brand, and Anthem pre-rolls. The company has also introduced a 72-hour Flower Satisfaction Guarantee for premium eighths from Grassroots and Reef brands.
A grand opening celebration is scheduled for August 8, 2025, featuring various activities and a Live Lounge livestream with cultivation leaders.
Curaleaf (OTCQX: CURLF), a leading international cannabis consumer products company, has scheduled its Q2 2025 financial results announcement for August 6, 2025, after market close.
The company will host a conference call and webcast at 5:00 p.m. ET on the same day, featuring management's prepared remarks and a Q&A session. The earnings call will be accessible via phone using different dial-in numbers for U.S., Canadian, and International participants, with replay available until August 13, 2025.
Curaleaf Holdings (OTCQX: CURLF) has acquired the remaining equity stake in Curaleaf International Holdings Limited from a strategic institutional investor, bringing its ownership to 100%. The transaction, completed on July 2, 2025, was executed through a pre-existing Put/Call Option agreement from 2021.
The strategic investor chose to receive payment entirely in Curaleaf Subordinate Voting Shares, demonstrating confidence in the company's future. The Toronto Stock Exchange conditionally approved the share issuance on June 25, 2025. This consolidation strengthens Curaleaf's control over European operations and enhances strategic alignment across international markets.
Curaleaf Holdings (CURLF) has announced the opening of a new medical cannabis dispensary in Punta Gorda, Florida, marking its 67th location in the state and 153rd nationwide. The new store, located at 100 Madrid Blvd., will begin serving medical patients on May 23, 2025. The dispensary will offer Curaleaf's comprehensive product portfolio, including Select BRIQ vapes, Select RSO X-Bites, Anthem pre-rolls, Grassroots Dark Heart Collection, and the Florida-exclusive Reef flower brand.
The company has introduced a new patient discount structure offering 60% off for new patients' first three visits, along with everyday discounts for seniors, students, veterans, and their spouses. A grand opening celebration is scheduled for May 30, 2025, featuring live music, giveaways, and special promotions.
Curaleaf Holdings (CURLF) has opened its newest dispensary in Lima, Ohio, located at 2151 Elida Rd. This marks the company's third location in Ohio and brings its nationwide retail footprint to 152 locations. The Lima dispensary features a drive-through pick-up window and operates from 9:00 AM to 8:00 PM Monday through Saturday, and 9:00 AM to 7:00 PM on Sundays.
The new location will serve both medical patients and adult-use customers in northwest Ohio, offering products from trusted brands including Select BRIQ all-in-one vapes, Grassroots flower, JAMS edibles, and Find flower. A ribbon-cutting ceremony with the Lima Chamber of Commerce will be announced at a later date, featuring promotional offers and celebrations.
Curaleaf Holdings (CURLF) has announced its entry into the Australian medical cannabis market through the launch of Curaleaf branded products. The initial offering includes four cannabis flower strains that will be distributed through Canngea, a licensed Australian manufacturer and wholesaler.
The company plans to expand its portfolio in the coming months with precision-dosed inhalation formats and popular strains currently prescribed in the UK, Germany, and other European markets. The Australian market is projected to exceed $1 billion in annual sales next year, representing a significant opportunity for Curaleaf's global expansion strategy.